Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-05

Clinical Trial Update: Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating standard chemotherapy with blueberry powder for non-small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Blueberry powder (blueberry powder)

Snippet

Sponsor: University of Louisville | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: TERMINATED